AbCellera Biologics Inc. SEC filings ABCL
AbCellera Biologics Inc. has 322 filings in SEC EDGAR's recent list, going back to Apr 6, 2017. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Aug 24, 2026 | Aug 24, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 18, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 13, 2026 | Aug 12, 2026 |
| 424B5 | Prospectus supplement | Aug 13, 2026 | — |
| 4 | Insider transaction | Aug 13, 2026 | Aug 11, 2026 |
| 424B5 | Prospectus supplement | Aug 11, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Other events
|
Aug 7, 2026 | Aug 7, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Other events
|
Jul 29, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 3 | Initial insider ownership | Jul 6, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Jun 17, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2026 | Jun 11, 2026 |
| 3 | Initial insider ownership | Jun 11, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 5, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 11, 2026 | May 11, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 7, 2026 | — |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 27, 2026 |
| S-8 | Employee stock plan registration | Feb 24, 2026 | — |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 14, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Dec 19, 2025 | Dec 1, 2025 |
| 3 | Initial insider ownership | Dec 19, 2025 | Nov 10, 2025 |
| 4 | Insider transaction | Dec 19, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 18, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Auditor change
|
Nov 28, 2025 | Nov 24, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 26, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 12, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Other events
|
Sep 10, 2025 | Sep 10, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2025 | Aug 7, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Other events
|
May 30, 2025 | May 30, 2025 |
| 8-K |
Current report
Other events
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Other events
|
May 13, 2025 | May 12, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 6, 2025 |
| S-3ASR | Automatic shelf registration | Feb 27, 2025 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Other events
|
Feb 18, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Dec 5, 2024 | Dec 4, 2024 |
| 4 | Insider transaction | Nov 26, 2024 | Nov 25, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 4, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2024 | Nov 4, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 9, 2024 | — |
| 4 | Insider transaction | Sep 24, 2024 | Sep 20, 2024 |
| 4 | Insider transaction | Aug 29, 2024 | Aug 29, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 21, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 31, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2024 | May 7, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Feb 27, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 23, 2024 | Feb 16, 2024 |
| S-8 | Employee stock plan registration | Feb 20, 2024 | — |
| 10-K | Annual report | Feb 20, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 20, 2024 | Feb 20, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 29, 2024 | — |
| 4 | Insider transaction | Jan 16, 2024 | Jan 14, 2024 |
| 4 | Insider transaction | Jan 16, 2024 | Jan 14, 2024 |
| 4 | Insider transaction | Jan 16, 2024 | Jan 14, 2024 |
| 4 | Insider transaction | Jan 16, 2024 | Jan 14, 2024 |
| 4 | Insider transaction | Dec 19, 2023 | Dec 19, 2023 |
| 8-K |
Current report
Other events
|
Nov 28, 2023 | Nov 28, 2023 |
| 4 | Insider transaction | Nov 27, 2023 | Nov 23, 2023 |
| 4 | Insider transaction | Nov 8, 2023 | Nov 6, 2023 |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Other events
|
Oct 13, 2023 | Sep 18, 2023 |
| 4 | Insider transaction | Sep 26, 2023 | Sep 22, 2023 |
| 4 | Insider transaction | Sep 14, 2023 | Sep 12, 2023 |
| 4 | Insider transaction | Aug 25, 2023 | Aug 24, 2023 |
| 4 | Insider transaction | Aug 9, 2023 | Aug 8, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | May 30, 2023 | May 26, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 26, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 26, 2023 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
May 24, 2023 | May 24, 2023 |
| 4 | Insider transaction | May 9, 2023 | May 5, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 4, 2023 | May 4, 2023 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | — |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | Apr 24, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 10, 2023 |
| 4 | Insider transaction | Feb 23, 2023 | Feb 22, 2023 |
| S-8 | Employee stock plan registration | Feb 21, 2023 | — |
| 10-K | Annual report | Feb 21, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 21, 2023 | Feb 21, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Jan 18, 2023 | — |
| 4 | Insider transaction | Dec 22, 2022 | Dec 20, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 5, 2022 | Dec 1, 2022 |
| 4 | Insider transaction | Dec 5, 2022 | Dec 1, 2022 |
| 4 | Insider transaction | Dec 5, 2022 | Dec 1, 2022 |
| 4 | Insider transaction | Dec 5, 2022 | Dec 1, 2022 |
| 4 | Insider transaction | Dec 5, 2022 | Dec 1, 2022 |
| 4 | Insider transaction | Dec 5, 2022 | Dec 1, 2022 |
| 4 | Insider transaction | Dec 5, 2022 | Dec 1, 2022 |
| 4 | Insider transaction | Nov 21, 2022 | Nov 18, 2022 |
| 4 | Insider transaction | Nov 9, 2022 | Oct 31, 2022 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2022 | Nov 8, 2022 |
| 4 | Insider transaction | Aug 22, 2022 | Aug 19, 2022 |
| 4 | Insider transaction | Aug 22, 2022 | Aug 18, 2022 |
| EFFECT | Filing | Aug 11, 2022 | — |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2022 | Aug 9, 2022 |
| UPLOAD | Letter from the SEC | Jul 28, 2022 | — |
| 10-K/A | Amended annual report | Jul 22, 2022 | Dec 31, 2021 |
| POS AM | Filing | Jul 22, 2022 | — |
| CORRESP | Letter to the SEC | Jul 22, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Jul 19, 2022 | Jul 9, 2022 |
| UPLOAD | Letter from the SEC | Jul 14, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Jul 6, 2022 | Jun 29, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 30, 2022 | Jun 29, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2022 | Jun 15, 2022 |
| 4 | Insider transaction | Jun 15, 2022 | Jun 13, 2022 |
| 4 | Insider transaction | Jun 8, 2022 | Jun 6, 2022 |
| 4 | Insider transaction | May 19, 2022 | May 18, 2022 |
| 4 | Insider transaction | May 17, 2022 | May 16, 2022 |
| 4 | Insider transaction | May 17, 2022 | May 13, 2022 |
| 4 | Insider transaction | May 16, 2022 | May 12, 2022 |
| 4 | Insider transaction | May 16, 2022 | May 12, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 10, 2022 | May 10, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 15, 2022 |
| 4 | Insider transaction | Mar 4, 2022 | Mar 4, 2022 |
| 4 | Insider transaction | Mar 3, 2022 | Mar 1, 2022 |
| 4 | Insider transaction | Mar 1, 2022 | Feb 28, 2022 |
| S-3ASR | Automatic shelf registration | Feb 25, 2022 | — |
| POS AM | Filing | Feb 25, 2022 | — |
| S-8 | Employee stock plan registration | Feb 25, 2022 | — |
| 10-K | Annual report | Feb 25, 2022 | Dec 31, 2021 |
| 4 | Insider transaction | Feb 25, 2022 | Feb 22, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 24, 2022 | Feb 24, 2022 |
| 424B3 | Prospectus | Feb 16, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 15, 2022 | Feb 11, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2022 | — |
| 5 | Annual insider ownership | Feb 3, 2022 | Dec 31, 2021 |
| 5 | Annual insider ownership | Feb 3, 2022 | Dec 31, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABCL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver, British Columbia, Canada
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1703057
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.